Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-3,page-paged-3,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.1,vc_responsive

CLIENT NEWS

 

 

  • VAXIMM Appoints Thomas D. Szucs, MD, as Chairman of the Board
    www.vaximm.com
  • APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
    www.apeiron-biologics.com
  • HepaRegeniX GmbH achieves successful proof of efficacy in acute liver disease models for selected MKK4 inhibitors
    www.heparegenix.com/
  • Rentschler Biopharma SE: The key to tackling drug development complexity: Collaboration. Rentschler Biopharma and Vetter team up with joint goal to simplify
    www.rentschler-biopharma.com
  • Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
    www.abivax.com
  • PAION announces U.S. FDA Approval of remimazolam (BYFAVOTM) for the induction and maintenance of procedural sedation
    www.paion.com
  • Publication in PNAS unveils molecular pathway required for influenza virus replication with large potential as an antiviral drug target
    www.atriva-therapeutics.com
  • MagForce AG Publishes Financial Results for the Year 2019 and Operative Highlights
    www.magforce.de
  • CENTOGENE AG: CENTOGENE, Lufthansa, and Fraport Launch the First Walk-In COVID-19 Testing Facility in Germany at Frankfurt Airport
    www.centogene.com
  • Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020
    www.heidelberg-pharma.com